• 1601 Citations
1993 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Ian Fleming is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Positron-Emission Tomography Medicine & Life Sciences
Integrins Chemical Compounds
Peptidomimetics Chemical Compounds
Neoplasms Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Peptides Chemical Compounds
Positron emission tomography Chemical Compounds
Tumors Chemical Compounds

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1993 2019

  • 1601 Citations
  • 45 Article
  • 2 Editorial
  • 1 Literature review
  • 1 Review article

A role for spinal cord hypoxia in neurodegeneration

Hernandez Gerez, E., Fleming, I. N. & Parson, S. H., 13 Nov 2019, In : Cell Death & Disease. 10, 8 p., 861.

Research output: Contribution to journalReview article

Open Access
File
Blood Vessels
Spinal Cord
Sclerosis
Pathology
Spinal Muscular Atrophy
3 Citations (Scopus)

Enzymatic radiosynthesis of a 18F-Glu-Ureido-Lys ligand for the prostate-specific membrane antigen (PSMA)

Lowe, P. T., Dall'Angelo, S., Fleming, I. N., Piras, M., Zanda, M. & O'Hagan, D., 2019, In : Organic & Biomolecular Chemistry. 17, 6, p. 1480-1486 7 p.

Research output: Contribution to journalArticle

antigens
Ligands
membranes
ligands
cancer
6 Citations (Scopus)
7 Downloads (Pure)
Open Access
File
Integrins
Mitogen-Activated Protein Kinase Kinases
Talin
Pharmacology
Glioblastoma

Two Years On: How the Core Curriculum has Shaped Pharmacology Courses at the University of Aberdeen

Tucker, S., Fleming, I. N., Hislop, J. N., Murray, F., Scott, D. A. & Wallace, H. M., 2018, Pharmacology Matters, 11, 3, p. 5-7 3 p.

Research output: Contribution to specialist publicationArticle

pharmacology
curriculum
quality assurance
resources
education
1 Citation (Scopus)
5 Downloads (Pure)

Design and synthesis of an RGD peptidomimetic-paclitaxel conjugate targeting αvβ3 integrin for tumour-directed drug delivery

Piras, M., Andriu, A., Testa, A., Wienecke, P., Fleming, I. N. & Zanda, M., 2017, In : Synlett. 28, 20, p. 2769-2776 8 p.

Research output: Contribution to journalArticle

Open Access
File
Peptidomimetics
Paclitaxel
Drug delivery
Integrins
Tumors